Baseline neutrophil-to-eosinophil-ratio and outcome in metastatic clear-cell renal cell carcinoma treated with nivolumab or ipilimumab/nivolumab

Baseline neutrophil-to-eosinophil-ratio and outcome in metastatic clear-cell renal cell carcinoma treated with nivolumab or ipilimumab/nivolumab

Background and purpose: This study aims to evaluate neutrophil-to-eosinophil ratio (NER) as a prognostic and/or predictive biomarker in metastatic clear cell renal cell carcinoma (m-ccRCC) treated with nivolumab or ipilimumab/nivolumab. Patients/materials and methods: We performed a retrospective s...

Full description

Bibliographic Details
Main Authors: Yana Beulque, Lisa Kinget, Eduard Roussel, Sajedeh Mobaraki, Annouschka Laenen, Philip R. Debruyne, Yannick Van Herck, Marcella Baldewijns, Agnieszka Wozniak, Abhishek D. Garg, Jessica Zucman-Rossi, Gabrielle Couchy, Maarten Albersen, Liesbeth De Wever, Lorenz Haaker, Benoit Beuselinck
Format: Article
Language:English
Published: Medical Journals Sweden 2024-08-01
Series:Acta Oncologica
Subjects:
renal cell carcinoma
neutrophil-to-eosinophil ratio
checkpoint inhibitor
immunotherapy
biomarker
Online Access:https://medicaljournalssweden.se/actaoncologica/article/view/40390

Internet

https://medicaljournalssweden.se/actaoncologica/article/view/40390

Similar Items